Cardiology

The link between high-risk human papillomavirus infection and atherosclerotic cardiovascular disease mortality was strongest in women with obesity.

Light-to-moderate alcohol consumption offers more protection against ischemic heart disease (IHD) mortality for individuals with higher socioeconomic status, potentially due to unequal access to health care.

Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Data demonstrated a 20% risk reduction for major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease.

A recent study found that women were less likely to get LDL-C testing and be treated with statins, despite having higher levels of LDL-C and higher blood pressure than men.

LIB Therapeutics released data from the LIBerate-HeFH trial that showed lerodalcibep achieved statistically significant placebo adjusted reductions in mean LDL-C at Week 24 and at the mean of Weeks 22 and 24.

Recent safety data also allowed four adverse events to be removed from the label.

Nearly two-thirds of individuals with T2D eventually develop atherosclerotic cardiovascular disease in the United States.

Patients were more likely to require ICU admission.

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

Results of an analysis of the VOYAGER PAD clinical trial were presented at ACC.23.

Researchers shared findings from the ACCESS study presented at the 72nd American College of Cardiology Annual Scientific Sessions.

After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR

A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.

Pharmacists can play an important role in patients’ wellness journeys.

Pradaxa (dabigatran) and Coumadin (warfarin) came out even in this randomized study. The Brazilian researchers who conducted the study said one explanation for the result is that use of Coumadin was exceptionally well managed because the patients were enrolled a study.

Mount Sinai study is the first to identify that heart attack, stroke and heart failure are linked to a specific type of age-related macular degeneration.

According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.

US Preventive Services Task Force hasn't endorsed screening for atrial fibrillation. Findings from these two studies might factor into a reconsideration.

Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.

New research looks at the potential benefits of long-term statin use in patients who are at increased risk of cardiovascular disease.

Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.

Lack of blood clotting may afford some protection against common cardiovascular disease events, such as ischemic stroke.

New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.